41Indexed trials
mesh condition
Parkinson Disease 4, Autosomal Dominant Lewy Body
Intelligence
Parkinson Disease 4, Autosomal Dominant Lewy Body intelligence: 41 indexed trials, 13 recruiting studies, 11 sponsors across 54 countries.
13Recruiting
11Sponsors
54Countries
Leading sponsors
Merck Sharp & Dohme LLC2911 recruiting
Incyte Corporation30 recruiting
MODAG GmbH10 recruiting
Michael J. Fox Foundation for Parkinson's Research10 recruiting
NYU Langone Health10 recruiting
Shandong New Time Pharmaceutical Co., LTD10 recruiting
Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University11 recruiting
University Hospital Schleswig-Holstein11 recruiting
Chinese Academy of Medical Sciences10 recruiting
Universität des Saarlandes10 recruiting
Invicro10 recruiting
Geographic activity
United States30trials
Spain22trials
Chile20trials
Canada20trials
Germany19trials
Italy19trials
Poland19trials
Israel18trials
France18trials
South Korea18trials
Australia17trials
Japan16trials
Leading interventions
Pembrolizumab21trials
Carboplatin11trials
Cisplatin10trials
Paclitaxel6trials
Gemcitabine4trials
pembrolizumab4trials
Epacadostat3trials
Pemetrexed3trials
Cyclophosphamide3trials
Docetaxel3trials
Capecitabine3trials
Cetuximab3trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.